Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov 16;14(11):e31565.
doi: 10.7759/cureus.31565. eCollection 2022 Nov.

B-cell Lymphoblastic Lymphoma of the Paranasal Sinuses: A Case Study of a Rare Clinical Entity

Affiliations
Case Reports

B-cell Lymphoblastic Lymphoma of the Paranasal Sinuses: A Case Study of a Rare Clinical Entity

Brian P Anderson et al. Cureus. .

Abstract

Lymphoblastic lymphoma is a rare and aggressive form of non-Hodgkin lymphoma (NHL). The tumor can derive from T-cell or B-cell and is clinically similar to acute lymphoblastic leukemia with minimal to no bone marrow involvement distinguishing the two. We present a rare case of lymphoblastic lymphoma originating from the paranasal sinuses. A 40-year-old male presented to the emergency department and was diagnosed with right-sided acute sinusitis complicated by pre-septal cellulitis. After failing medical management, he underwent endoscopic sinus surgery. Pathologic analysis of nasal contents stained for CD79a, CD34, and PAX5, suggesting a B-cell lymphoblastic lymphoma (B-LBL). He was referred to hematology-oncology and was treated with hyperfractionated cyclophosphamide, vincristine, Adriamycin, dexamethasone (Hyper-CVAD). Short-term follow-up has thus far demonstrated near-complete resolution of the tumor. Non-Hodgkin lymphomas of the paranasal sinuses are rare, and B-cell lymphoblastic lymphomas comprise just 0.3% of adults with NHL. Immunohistochemical phenotyping for B-LBL is typically positive for B-cell markers CD19, CD20, CD22 and CD79a. Classic treatment involves a chemotherapy regimen of Hyper-CVAD with an overall survival rate of 66%. B-cell lymphoblastic lymphoma is rarely reported in the paranasal sinuses. A thorough history and physical exam along with a complete workup, including biopsies with histopathological and immunohistochemical analysis, needs to be obtained. Little is known about its prognosis when the primary site is within the paranasal sinuses, and therefore, patients need prompt and aggressive treatment when the diagnosis is made.

Keywords: acute sinusitis; b lymphoblastic lymphoma; non hodgkin's lymphoma; paranasal sinus neoplasm; primary sinonasal lymphoma.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Computed tomography (CT) without contrast
(A) Axial, (B) coronal, and (C) sagittal computed tomography (CT) without contrast showing a mass-like lesion occupying the paranasal sinuses, particularly involving the right maxillary, ethmoid, frontal and sphenoid sinus with extension into the right nasopharynx and left ethmoid sinus
Figure 2
Figure 2. Pathological analysis of sinus contents
A) Histologic examination (hematoxylin-eosin stain) of nasal contents with diffuse lymphocytic infiltration, 40X magnification. (B) Immunohistochemical stain of sinus contents is positive for Ki-67, 40X magnification. (C) Immunohistochemical stain of sinus contents is positive for CD79a, 40X magnification.

References

    1. Wang TF, Barlett NL. Cummings Otolaryngology: Head and Neck Surgery, 6th Edition. Philadelphia: Elsevier Saunders; 2015. Lymphomas of the head and neck; pp. 2123–2125.
    1. Paranasal sinus lymphoma: retrospective review with focus on clinical features, histopathology, prognosis, and relationship to systemic lymphoma. Wajda BN, Rabinowitz MR, Nyquist GG, Mardekian SK, Rosen MR, Rabinowitz MP. Head Neck. 2017;39:1065–1070. - PubMed
    1. Lymphoma. Mugnaini EN, Ghosh N. Prim Care. 2016;43:661–675. - PubMed
    1. Fatal primary diffuse large B-cell lymphoma of the maxillary sinus initially treated as an infectious disease in an elderly patient: a clinicopathologic report. de Castro MS, Ribeiro CM, de Carli ML, Pereira AA, Sperandio FF, de Almeida OP, Hanemann JA. Gerodontology. 2018;35:59–62. - PubMed
    1. Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era. Takahashi H, Tomita N, Yokoyama M, et al. Cancer. 2012;118:4166–4172. - PubMed

Publication types

LinkOut - more resources